Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-05

Clinical Trial Update: Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating whether thyroid hormone can induce non-insulin mediated glucose disposal in individuals with insulin receptor mutations; tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thyroid hormone

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Insulin Resistance, Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2019-12-05